REGULAXIS SAS
Regulaxis mission is to grant licenses of innovative molecules after phase II clinical records.
REGULAXIS SAS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2013-12-01
Address:
Romainville, Ile-de-France, France
Country:
France
Website Url:
http://www.regulaxis.com
Total Employee:
1+
Status:
Active
Contact:
+33660904124
Email Addresses:
[email protected]
Total Funding:
3.21 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Apache
Similar Organizations
ATAI Life Sciences
ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Regulaxis SAS
Newest Events participated
Official Site Inspections
http://www.regulaxis.com Semrush global rank: 5.59 M Semrush visits lastest month: 581
- Host name: 81.88.48.95
- IP address: 81.88.48.95
- Location: Italy
- Latitude: 43.1479
- Longitude: 12.1097
- Timezone: Europe/Rome
More informations about "Regulaxis SAS"
REGULAXIS a French Innovative Biotechnology Company
REGULAXIS a French Innovative Biotechnology Company Based at BIOCITECH the technology park of life science of Paris North area. The company is engaged in the research, …See details»
About us - Regulaxis
Regulaxis SAS is a biotech company created in 2013 by Claude Carelli to develop innovative therapies for human clinic based on new synthetic peptides regulating cell growth and …See details»
Team - Regulaxis
Welcome to REGULAXIS, a French Innovative Biotechnology Company based at BIOCITECH, the technology park of life science of Paris North area. A new hope for OsteoArthritic patients …See details»
Regulaxis SAS - LinkedIn
REGULAXIS is a French innovative biotechnology company based at BIOCITECH the technology park of life science of Paris North area. The company is engaged in the research, development and...See details»
Regulaxis SAS - Crunchbase Company Profile & Funding
Regulaxis mission is to grant licenses of innovative molecules after phase II clinical records. A chemically synthesized peptide for intra-articular injection …See details»
Regulaxis Company Profile 2024: Valuation, Funding & Investors
Regulaxis is headquartered in Romainville, France. What is the size of Regulaxis? Regulaxis has 6 total employees. What industry is Regulaxis in? Regulaxis’s primary industry is …See details»
Regulaxis - VentureRadar
Website: http://www.regulaxis.com. REGULAXIS is engaged in the research, development and licensing of innovative synthetic molecules for use in human therapies. REGULAXIS leads its …See details»
Regulaxis Company Profile - Office Locations, Competitors, …
Regulaxis is a biotechnology company that is engaged in the research, development, and licensing of synthetic molecules for use in human treatments. It provides therapies based on …See details»
Claude Carelli - Founder of REGULAXIS, French Biotechnology
Président, fondateur de REGULAXIS SAS · The biotechnology company REGULAXIS is engaged in the research, development and licensing of innovative synthetic molecules for use in human …See details»
Regulaxis, la Recherche et Développement dans le domaine ... - Le …
Jul 8, 2019 · Créé en 2013, Regulaxis propose un médicament pour le traitement thérapeutique de l’arthrose, en particulier du genou. Aujourd’hui, il n’y a pas de molécule existante ni de …See details»
Regulaxis DMF, CEP, Written Confirmations, FDF, Prices, Patents ...
REGULAXIS is a French innovative biotechnology company based at BIOCITECH the technology park of life science of Paris North area. The company is engaged in the research, …See details»
REGULAXIS Company Profile | ROMAINVILLE, ILE DE FRANCE, …
Find company research, competitor information, contact details & financial data for REGULAXIS of ROMAINVILLE, ILE DE FRANCE. Get the latest business insights from Dun & Bradstreet.See details»
R&D - Regulaxis
Regulaxis is engaged in the R&D of molecules that can advantageously be proposed to treat. Reconstitution and repair of articular cartilage by stimulation of chondrocytes, cartilage-forming …See details»
Regulaxis - Products, Competitors, Financials, Employees, …
Regulaxis is a biotechnology company focusing on the research, development, and licensing of synthetic molecules for human therapies. Use the CB Insights Platform to explore Regulaxis's …See details»
Regulaxis CEO and Key Executive Team | Craft.co
Regulaxis's President & CEO is Claude Carelli. Other executives include Christelle Vêtu, COO; Matthieu Chareyre, Executive Director Industrial Operations. See the full leadership team at …See details»
Regulaxis' new drug for OA therapy is raising interest - LinkedIn
Jan 10, 2018 · Regulaxis will present its REG-O3 data at next OARSI international conference:NEW CHIMERIC PEPTIDES REGULATING IGF-1 SHOW SIGNIFICANT …See details»
Artialis - Your partner for drug development
Regulaxis (France) chooses Artialis Group for the development of its new treatment against osteoarthritis! Published on 25/06/2018. Partnership between Artialis & Regulaxis!See details»
REGULAXIS (ROMAINVILLE) Chiffre d'affaires, résultat, bilans sur ...
Jan 2, 2020 · REGULAXIS, société par actions simplifiée, immatriculée sous le SIREN 795204981, est active depuis 9 ans. Implantée à ROMAINVILLE (93230), elle est spécialisée …See details»
News - Regulaxis
Jun 1, 2021 · Basé à Biocitech, le parc technologique des Sciences de la Vie, juste à côté de Paris, Regulaxis est une entreprise engagée dans la recherche, le développement et la …See details»
Conférence: "L'arthrose, espoir grâce à une nouvelle molécule …
Regulaxis est une start-up française travaillant dans les développements thérapeutiques, financée par la France et par une participation européenne assez difficile à obtenir (ce qui démontre, de …See details»